CONTROVERSIA

This profile has not been translated into English yet. It is shown in French, the reference language (automatic translation tools in your browser can help). Legal statuses and counts are shown in English.

Portrait of ResMed

Portrait: Openverse / flickr — Lkamada Oxisono Cpap Sono — by-nc 2.0 · source

Sommeil / ventilation / PAP / santé numérique / logiciels de soins hors hôpital

ResMed

Fiche documentée couvrant 21 controverses, dont « Fondation de ResCare pour commercialiser la thérapie PAP » et « Licence du masque nasal Bubble Cushion ».

Your opinion of this profile

Profile No. 5161 · Updated on 26 September 2026

21Documented controversies
14Sources
0Formal charge · all time
0Conviction

§ Legal statuses reflect the documented sources as of the date shown; they replace neither court decisions nor the presumption of innocence. Counts are not a rating. Methodology

I. Documented controversies

01

2025-2026

Actions en contrefaçon Fractus et Cleveland Medical

Status not specified

Not yet available in English — French original shown.

ResMed est visé par plusieurs actions brevets portant notamment sur AirSense/AirCurve, ApneaLink et certaines plateformes associées ; le groupe demande des rejets et sollicite parallèlement des procédures PTAB.

Legal status — source text
pending

Sources · 1

  1. [1]
    ResMed / SECResMed 2026 Form 10-KVery high reliability

Last verified: 21 September 2026

02

2021-15 mai 2026

Action whistleblower VA rejetée contre ResMed

Status not specified

Not yet available in English — French original shown.

Une plainte qui tam alléguant une conspiration de surfacturation de produits CPAP à la Veterans Administration est dévoilée en 2025. Le gouvernement refuse d’intervenir ; le demandeur retire volontairement la plainte contre ResMed le 20 avril 2026 et le gouvernement consent au retrait le 15 mai.

Sources · 1

  1. [1]
    ResMed / SECResMed 2026 Form 10-KVery high reliability

Last verified: 21 September 2026

03

1er juin 2026

Acquisition de Noctrix Health

Status not specified

Not yet available in English — French original shown.

ResMed finalise l’acquisition de Noctrix Health et ajoute Nidra, dispositif de neurostimulation classé De Novo par la FDA pour certains patients atteints du syndrome des jambes sans repos.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMedResmed Completes Acquisition of Noctrix HealthHigh reliability

Last verified: 21 September 2026

04

30 juin-7 juillet 2026

Accord de vente de MatrixCare à Frazier Healthcare Partners

Status not specified

Not yet available in English — French original shown.

ResMed conclut un accord de vente de MatrixCare pour 490 M$ afin de recentrer le portefeuille sur le sommeil, la respiration et les soins connectés à domicile.

Sources · 1

  1. [1]
    ResMedResmed Announces Agreement to Sell MatrixCare BusinessHigh reliability

Last verified: 21 September 2026

05

25 juin-31 juillet 2026

Rappel Class I Astral 100/150 pour risque d’interruption de ventilation

Status not specified

Not yet available in English — French original shown.

ResMed corrige certains ventilateurs Astral 100/150 : une fuite d’électrolyte d’un supercondensateur peut endommager la carte et provoquer un état fail-safe interrompant la ventilation.

Sources · 1

  1. [1]
    U.S. Food and Drug AdministrationClass 1 Device Recall Resmed Astral 100/150Very high reliability

Last verified: 21 September 2026

06

2025

Acquisition de VirtuOx

Status not specified

Not yet available in English — French original shown.

ResMed acquiert VirtuOx, structure de diagnostic à distance et testing à domicile, renforçant les parcours de diagnostic du sommeil et respiratoires.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMed / SECResMed 2026 Form 10-KVery high reliability

Last verified: 21 September 2026

07

novembre 2022

Acquisition de MEDIFOX DAN

Status not specified

Not yet available in English — French original shown.

ResMed acquiert MEDIFOX DAN pour environ 1 Md$ et étend sa stratégie SaaS hors hôpital au marché allemand.

Legal status — source text
completed

Sources · 2

  1. [1]
    ResMedResMed to Acquire MEDIFOX DANHigh reliability
  2. [2]
    ResMed / SECResMed 2023 Form 10-KVery high reliability

Last verified: 21 September 2026

08

2021

Acquisition de CitusHealth

Status not specified

Not yet available in English — French original shown.

ResMed acquiert CitusHealth, logiciel de communication et partage de documents pour soins à domicile.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMedResMed SaaS historyMedium reliability

Last verified: 21 September 2026

09

15 janvier 2020

Règlement False Claims Act de 37,5 M$

Civil / administrative proceedings

Not yet available in English — French original shown.

ResMed Corp. accepte de payer plus de 37,5 M$ pour résoudre des allégations de kickbacks liés notamment à des services gratuits ou à prix réduit, prêts garantis et dispositifs de test du sommeil.

Sources · 1

  1. [1]
    U.S. Department of JusticeResMed to Pay $37.5 Million to Resolve False Claims Act AllegationsVery high reliability

Last verified: 21 September 2026

10

2019

Acquisition de Propeller Health

Status not specified

Not yet available in English — French original shown.

ResMed acquiert Propeller Health, plateforme numérique de suivi des traitements inhalés pour asthme et BPCO.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMedResMed SaaS historyMedium reliability

Last verified: 21 September 2026

11

juillet 2018

Acquisition de HEALTHCAREfirst

Status not specified

Not yet available in English — French original shown.

ResMed acquiert HEALTHCAREfirst, étendant son portefeuille de logiciels aux soins à domicile et hospice.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMed / SECResMed 2024 Form 10-K – SaaS acquisitionsVery high reliability

Last verified: 21 September 2026

12

14 novembre 2018

Acquisition de MatrixCare

Status not specified

Not yet available in English — French original shown.

ResMed acquiert MatrixCare pour 750 M$, renforçant ses logiciels pour skilled nursing, senior living et autres soins hors hôpital.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMedResMed Completes Acquisition of MatrixCareHigh reliability

Last verified: 21 September 2026

13

4 avril 2016

Acquisition de Brightree

Status not specified

Not yet available in English — French original shown.

ResMed acquiert Brightree pour environ 800 M$, entrant fortement dans les logiciels cloud pour soins post-aigus et DME/HME.

Legal status — source text
completed

Sources · 2

  1. [1]
    ResMedResMed to Acquire Brightree for $800 MillionHigh reliability
  2. [2]
    ResMed / SECResMed 2018 Form 10-K – Brightree acquisitionVery high reliability

Last verified: 21 September 2026

14

années 2000-2010

Développement d’AirView et du suivi connecté

No legal proceedings

Not yet available in English — French original shown.

ResMed développe des solutions de suivi à distance et de connectivité destinées à la gestion de la thérapie du sommeil et de la ventilation.

Legal status — source text
Not applicable

Sources · 1

  1. [1]
    ResmedOur HistoryHigh reliability

Last verified: 21 September 2026

15

septembre 1999

Transfert de la cotation principale au NYSE

Status not specified

Not yet available in English — French original shown.

ResMed transfère sa cotation principale au NYSE sous le symbole RMD.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMed / SECResMed 2022 Form 10-K – corporate historyVery high reliability

Last verified: 21 September 2026

16

novembre 1999

Cotation secondaire en Australie

Status not specified

Not yet available in English — French original shown.

ResMed établit une cotation secondaire via CDIs sur l’Australian Stock Exchange.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMed / SECResMed 2022 Form 10-K – corporate historyVery high reliability

Last verified: 21 September 2026

17

1995

Changement de nom de ResCare à ResMed

No legal proceedings

Not yet available in English — French original shown.

La société adopte le nom ResMed, contraction de Respiratory Medicine.

Legal status — source text
Not applicable

Sources · 1

  1. [1]
    ResmedOur HistoryHigh reliability

Last verified: 21 September 2026

18

juin 1995

Introduction au Nasdaq

Status not specified

Not yet available in English — French original shown.

ResMed réalise son IPO et commence à être coté au Nasdaq National Market.

Legal status — source text
completed

Sources · 1

  1. [1]
    ResMed / SECResMed 2022 Form 10-K – corporate historyVery high reliability

Last verified: 21 September 2026

19

mars 1994

Création de ResMed Inc. comme holding américaine

No legal proceedings

Not yet available in English — French original shown.

ResMed Inc. est constituée au Delaware comme société holding ultime des filiales opérationnelles.

Legal status — source text
Not applicable

Sources · 1

  1. [1]
    ResMed / SECResMed 2022 Form 10-K – corporate historyVery high reliability

Last verified: 21 September 2026

20

1990

Licence du masque nasal Bubble Cushion

No legal proceedings

Not yet available in English — French original shown.

Le premier masque PAP préassemblé Bubble Cushion est breveté puis licencié exclusivement à ResCare.

Legal status — source text
Not applicable

Sources · 1

  1. [1]
    ResmedOur HistoryHigh reliability

Last verified: 21 September 2026

21

29 mai 1989

Fondation de ResCare pour commercialiser la thérapie PAP

No legal proceedings

Not yet available in English — French original shown.

Peter Farrell fonde ResCare afin de commercialiser des équipements de pression positive pour l’apnée du sommeil.

Legal status — source text
Not applicable

Sources · 1

  1. [1]
    ResmedOur HistoryHigh reliability

Last verified: 21 September 2026

II. Constellation of documented links

No documented link with another published profile for now.

A documented mention does not, on its own, prove a personal relationship.

III. Your opinion of this profile

One opinion per browser, which you can change at any time. It rates the quality of the profile, not the person.

IV. Has something changed?

A new court decision, a missing source, a mistake? Tell us what should be updated: every request is read by the editorial team.

Update request

ResMed

Say which controversy is concerned and, if possible, give a source. Between 10 and 2,500 characters.

0 / 2500